Sectors
NTLA
Intellia Therapeutics, Inc.
11.13
1 x 11.12
2 x 11.13
bid
ask
-
0.34
2.96%
12:29 PM
timesize
| Ytd | 23.80% | |
| 1y | -17.49% |
11.13
day range
11.46
7.95
52 week range
28.25
| Open | 11.25 | Prev Close | 11.47 | Low | 11.13 | High | 11.46 | Mkt Cap | 1.29B |
| Vol | 991.58K | Avg Vol | 6.96M | EPS | -3.55 | P/E | -3.23 | Forward P/E | -8.25 |
| Beta | 1.77 | Short Ratio | 7.30 | Inst. Own | 76.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 14.10 | 200-d Avg | 13.54 | 1yr Est | 26.17 |
| Income Statement | |||
| Total Revenue | 15.05M | ||
| Revenues (USD) | 15.05M | ||
| Gross Profit | 15.05M | ||
| Operating Expenses | 115.58M | ||
| Research and Development Expense | 80.74M | ||
| Selling, General and Administrative Expense | 34.84M | ||
| Operating Income | -100.53M | ||
| Net Income | -96.23M | ||
| Net Income Common Stock | -96.23M | ||
| Net Income Common Stock (USD) | -96.23M | ||
| Consolidated Income | -96.23M | ||
| Earnings per Basic Share | -0.81 | ||
| Earnings per Basic Share (USD) | -0.81 | ||
| Earnings per Diluted Share | -0.81 | ||
| Earning Before Interest & Taxes (EBIT) | -96.23M | ||
| Earning Before Interest & Taxes (USD) | -96.23M | ||
| Weighted Average Shares | 118.49M | ||
| Weighted Average Shares Diluted | 118.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 134.70M | ||
| Cash and Equivalents (USD) | 134.70M | ||
| Investments | 420.56M | ||
| Investments Current | 241.29M | ||
| Investments Non-Current | 179.27M | ||
| Trade and Non-Trade Receivables | 9.13M | ||
| Current Assets | 466.45M | ||
| Property, Plant & Equipment Net | 113.06M | ||
| Total Assets | 758.78M | ||
| Debt Current | 19.10M | ||
| Total Debt | 80.49M | ||
| Current Liabilities | 76.44M | ||
| Debt Non-Current | 61.40M | ||
| Total Liabilities | 137.84M | ||
| Accumulated Retained Earnings (Deficit) | -2.69B | ||
| Accumulated Other Comprehensive Income | -240.00K | ||
| Shareholders Equity | 620.94M | ||
| Shareholders Equity (USD) | 620.94M | ||
| Assets Non-Current | 292.33M | ||
| Total Debt (USD) | 80.49M | ||
| Deferred Revenue | 630.00K | ||
| Liabilities Non-Current | 61.40M | ||
| Trade and Non-Trade Payables | 18.80M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.20M | ||
| Net Cash Flow from Financing | 33.57M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -17.47M | ||
| Capital Expenditure | -79.00K | ||
| Issuance (Purchase) of Equity Shares | 33.57M | ||
| Net Cash Flow from Investing | 66.31M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 66.39M | ||
| Net Cash Flow from Operations | -117.35M | ||
| Share Based Compensation | 13.48M | ||